FREE GLOBAL SHIPPING ON ALL ORDERS OVER $100
We design and develop the worlds most advanced research peptide delivery system. Our goal is to support research scientists in every way possible. Please visit HiroScience Education to engage with our LLM and other researchers in the community.
GLP-1 Semaglutide
12 Units 1MG 30-Day Release Patches
$1,329
1
About This Product
Description
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with Semaglutide has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
Key Points
- Improves insulin secretion
- Enhances heart and lung function
- Suppresses appetite and reduces motility
- Potential Alzheimer’s benefits
- Less than 10% variance in concentration per lot, guaranteeing consistency.
- Formulated without corrosive agents for safety.
- Crimp-top glass aliquot to minimize degradation.
- Tamper-proof seal to ensure safety in transit.
- Batch and lot coded with publicly visible lab reports to ensure quality and transparency.
Usage
Apply patch to a clean, dry area of the skin. Use as directed by your physician.
Care
Store in a cool, dry place. Avoid exposure to sunlight. Store at ≤4°C, tightly sealed, away from heat, light and moisture.
Categories
Peptides, GLP-1, Longevity, Metabolic
SKU
PEP-GLP1-12U1MG30D
What is GLP-1 Semaglutide?
GLP-1, short for glucagon-like peptide-1 is a short, naturally occurring peptide hormone just 30-31 amino acids in length. Its primary physiologic function is to lower blood sugar levels by naturally enhancing insulin secretion. It also plays roles in protection beta cell insulin stores by promoting insulin gene transcription and has been linked with neurotrophic effects in the brain and central nervous system. In the GI system, GLP-1 has been shown to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Preliminary research has shown impacts of GLP-1 in the heart, fat, muscles, bones, liver, lungs, and kidneys as well.
The primary focus of GLP-1 research has been in the realm of diabetes treatment/prevention as well as appetite suppression. Secondary research focuses on the potential cardiovascular benefits of the peptide. More recent, and thus less robust, research focuses on the ability of GLP-1 to stave off neurodegenerative disease. Though this latter area of research is newest, it is also the fast-growing area of GLP-1 study now that the peptide has been revealed to slow or prevent the accumulation of amyloid beta plaques in the setting of Alzheimer's disease.
Hiro's Product Guarantees
Money Back Guarantee
Return or exchange your unopened product within 30 days no questions asked.
Satisfaction Guaranteed
If you are unsatisfied with your product within 7 days of delivery we will issue a full refund.
Easy Returns
The return process is simple, straightforward, and tracked at each step of the way.
Secure Ordering
Rest assured that our checkout is SSL encrypted and completely secure.
Next Day Shipping
Order today and we'll ship your product the next business day guaranteed.
3rd Party Testing
Our products are verified by independent laboratories to meet quality standards.
Batch & Lot Tracking
All product batches and lots are assigned unique identifiers and tied to publicly posted lab reports.
Product Clinical Info
Sequence
HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG
Molecular Formula
C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight
4113.64 g/mol
CAS Number
910463-68-2
PubChem ID
Synonyms
Semaglutide, Oxempic, Rybelsus, NN9535, 910463-68-2, UNII-53AXN4NNHX, Wegovy, NN 9535, NNC 0113-0217, 53AXN4NNHX, NN-9535, Rybelsus (oral semaglutide), Ozempic (injectable semaglutide), CHEBI:167574, NNC-0113-0217, Semaglutide [USAN:INN], Semaglutida, Semaglutidum, Oral Semaglutide, Semaglutide free base, Semaglutide(sodium salt)?, GTPL9724
Source: PubChem
3rd Party Testing Reports
Certificate of Analysis
Issued on January 1st, 2025
High-Performance Liquid Chromatography Analysis
Issued on January 1st, 2025
Mass Spectrometry Analysis
Issued on January 1st, 2025
Frequently Asked Questions
100+ Product Reviews
January 3rd, 2025
"I have been using the HiroScience GLP-1 Semaglutide patch for three months now, and I cannot recommend it enough! Before trying this patch, I struggled with managing my blood sugar levels and keeping my weight in check. Since starting this treatment, my energy levels have improved dramatically, and I've even lost 12 pounds without making any major changes to my routine. The convenience of the patch is unmatched—I just apply it once, and I’m good for the day. No more worrying about injections or remembering pills! Thank you, HiroScience, for creating such a life-changing product!"
Emily W
New York, NY
January 2nd, 2025
"I was skeptical at first, but the HiroScience GLP-1 Semaglutide patch has completely exceeded my expectations. It’s so easy to use, and I’ve noticed significant improvements in both my blood sugar levels and my overall well-being. My doctor is impressed with how stable my readings have become. On top of that, I’ve lost 15 pounds over the last two months, which has motivated me to adopt healthier habits. I feel like I finally have control over my health without the hassle of injections. This patch is a game-changer!"
Michael R
Los Angeles, CA
December 25th, 2024
"The HiroScience GLP-1 Semaglutide patch is a lifesaver. I used to dread taking my medications because of the needles, but this patch has made managing my diabetes so much easier. It’s comfortable to wear and incredibly effective. Since I started using it, my A1C levels have improved significantly, and I’ve noticed a boost in my energy and focus. I’ve also experienced gradual weight loss, which has been an added bonus. I’m so grateful for this innovative solution—it’s given me my life back!"
Sarah K
Wilmington, DE
December 23rd, 2024
"As someone who’s been dealing with type 2 diabetes for years, the HiroScience GLP-1 Semaglutide patch has been a breakthrough for me. It’s so simple to use, and it really works. I’ve seen a marked improvement in my blood sugar levels, and I’ve lost nearly 10 pounds since starting it two months ago. I love that it’s discreet and hassle-free—no more needles or daily reminders! My only wish is that I had discovered this patch sooner. HiroScience has truly created something revolutionary here."
James O
Miami, FL
January 15th, 2024
"I can’t say enough good things about the GLP-1 Semaglutide patch from HiroScience. It’s been a total game-changer for my health journey. I’ve struggled with weight loss and blood sugar control for years, but this patch has made such a difference. It’s so easy to apply, and I love that it works throughout the day without me having to think about it. My weight has dropped steadily, and my glucose levels are more consistent than they’ve ever been. I feel healthier, more confident, and in control. HiroScience, thank you for this amazing product!"
Olivia M
Las Vegas, NV
Shipping Details
Processing Time
1 Business Day (Not Including Weekends or Holidays)
Estimated Delivery Time
3-7 Business Days
Postal Carrier
United States Postal Service
Shipping Service
USPS Ground Advantage
International Shipping
Not available, we ship only within the United States of America.
Package Weight
3.5 oz
Package Dimensions
5 in x 5 in x 2 in (L x W x H)
Product Safety Instructions
General
Keep the microneedle patches out of reach of unauthorized personnel and ensure access is restricted to trained professionals. Familiarize yourself with the microneedle patch's Safety Data Sheet (SDS) for detailed handling and emergency information. Do not reuse microneedle patches or materials associated with their handling.
Handling
Always wear appropriate personal protective equipment (PPE), including gloves, lab coat, and safety goggles, when handling the microneedle patch. Avoid direct contact with the skin, eyes, and clothing during handling unless instructed by research protocol. In case of accidental contact with the active side of the patch, wash the affected area thoroughly with soap and water.
Storage
Store the microneedle patch at ≤4°C in a sealed container to maintain stability and prevent contamination. Avoid exposure to direct sunlight, heat, or moisture, as these may degrade the patch material or active ingredients. Keep the microneedle patch in a designated research-only storage area to ensure proper handling and prevent misuse.
Disposal
Dispose of used or unused microneedle patches, packaging, and related waste in accordance with local hazardous waste disposal regulations. Do not dispose of microneedle patches in household waste or drains. Use appropriate biohazard disposal methods if necessary.
Emergency
In case of accidental application, seek immediate medical attention and provide the product label or SDS (Safety Data Sheet) to the healthcare provider. For spills or damaged patches, clean the area with an appropriate chemical absorbent material and ventilate the area to ensure safety.
Related Products
GLP-1 Semaglutide
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with Semaglutide has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
1 Unit
1MG Dose
30-Day Release
Microneedle Patch
GLP-1 Semaglutide
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with Semaglutide has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
1 Unit
2MG Dose
30-Day Release
Microneedle Patch
Legal and Compliance
Disclaimer
Research Use Only. Not for Human or Veterinary Use.
This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All articles and product information provided on this website are for informational and educational purposes only. The products offered are not intended for human or animal consumption, nor for medical, veterinary, or household use. These products have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic. Please familiarize yourself with our Terms of Service prior to ordering.
We design and develop the worlds most advanced research peptide delivery system. Our goal is to support research scientists in every way possible. Please visit HiroScience Education to engage with our LLM and other researchers in the community.
Terms
Privacy
Refunds
Returns
Copyright © 2025 HiroScience. All Rights Reserved.